EMA — authorised 26 July 2018
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
🇪🇺 Aimovig in European Union
EMA authorised Aimovig on 26 July 2018
Marketing authorisation
Aimovig in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Aimovig approved in European Union?
Yes. EMA authorised it on 26 July 2018.
Who is the marketing authorisation holder for Aimovig in European Union?
NOVARTIS EUROPHARM LIMITED holds the EU marketing authorisation.